Selpercatinib


CAS No. : 2152628-33-4

(Synonyms: LOXO-292)

2152628-33-4
Price and Availability of CAS No. : 2152628-33-4
Size Price Stock
5mg $60 In-stock
10mg $100 In-stock
25mg $220 In-stock
50mg $350 In-stock
100mg $650 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-114370
M.Wt: 525.60
Formula: C29H31N7O3
Purity: >98 %
Solubility: DMSO : 62.5 mg/mL (ultrasonic)
Introduction of 2152628-33-4 :

Selpercatinib (LOXO-292) is a potent, selective RET kinase inhibitor with IC50 values of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively. Selpercatinib has anticancer activity[1][2]. IC50 & Target:IC50: 14.0 nM (RETWT), 24.1 nM (RETV804M), and 530.7 nM (RETG810R)[2] In Vivo: Selpercatinib (LOXO-292; 10 mg/kg; i.g.; for 0-2 h) has good pharmacokinetics after oral gavage in FVB/NRj mice[1].
Pharmacokinetic Parameters of Selpercatinib in FVB/NRj mice[1].
Administration i.g. (10 mg/kg)
Tmax (h) 1.8
Cmax (ng/mL) 7862
AUC (ng·h/mL) 26649
FVB/NRj mice, 10 mg/kg i.g.[1]

Your information is safe with us.